Enveda Raises $55M with Microsoft to Combine Ancient Remedies with AI for Drug Discovery

Jun 14, 2024, 10:10 AM

Boulder, Colorado-based Enveda has raised a $55 million Series B extension to combine ancient remedies with AI for drug discovery. The funding round included investors such as Microsoft. Enveda aims to leverage centuries-old knowledge of natural remedies and modern artificial intelligence to develop new pharmaceuticals. For instance, people chewed willow tree bark for pain relief long before Bayer isolated its active ingredient.